Thus, strategies aimed to break the perpetuating cycle of weight gain, insulin resistance and increased exogenous insulin requirements (Figure 2) are highly desirable in patients with double diabetes, where clinical features of both T1D and T2D coexist in the same subject [61]. The gene discussed is INS; the disease is type 1 diabetes mellitus.